Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sterilens Idra is a line of sterile, moisturizing, and lubricating eye drops developed by Eurospital for eye care and comfort. The product line includes formulations such as Sterilens Idra Active, Sterilens Idra Active HD Plus, Sterilens Idra Remedy, and Sterilens Idra Calm. The primary active ingredient in the main formulations is hyaluronic acid (sodium hyaluronate), a natural polymer that mimics the properties of the natural tear film to soothe irritation, relieve dryness, and maintain optimal ocular hydration. It is indicated for the relief of dry, red, and fatigued eyes caused by factors such as prolonged contact lens wear, environmental stressors (wind, dust, air conditioning), and extended screen time. Sterilens Idra is approved and marketed as a medical device in Italy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sterilens Idra.